TG Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company serves patients with conditions such as relapsed/refractory lymphomas, multiple sclerosis, and chronic lymphocytic leukemia.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.